Skip to main content

Advertisement

SpringerLink
Log in

Optimizing locoregional staging in the preoperative setting of resectable esophageal cancer

  • Letter
  • Published:
Surgical Endoscopy Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Erasmus JJ, Munden RF (2007) The role of integrated computed tomography positron-emission tomography in esophageal cancer: staging and assessment of therapeutic response. Semin Radiat Oncol 17:29–37

    Article  PubMed  Google Scholar 

  2. Choi J, Kim SG, Kim JS, Jung HC, Song IS (2010) Comparison of endoscopic ultrasonography (EUS), positron emission tomography (PET), and computed tomography (CT) in the preoperative locoregional staging of resectable esophageal cancer. Surg Endosc 24:1380–1386

    Article  PubMed  Google Scholar 

  3. Roukos DH (2010) Targeting gastric cancer with trastuzumab: new clinical practice and innovative developments to overcome resistance. Ann Surg Oncol 17:14–17

    Article  PubMed  Google Scholar 

  4. Roukos DH (2009) Genome-wide association studies and aggressive surgery toward individualized prevention and improved local control and overall survival for gastric cancer. Ann Surg Oncol 16:795–798

    Article  PubMed  Google Scholar 

  5. Roukos DH (2009) Radiation therapy for breast cancer. N Engl J Med 360:1362 (author reply 1363)

    Article  PubMed  CAS  Google Scholar 

  6. Ziogas D, Roukos DH (2009) CDH1 testing: can it predict the prophylactic or therapeutic nature of total gastrectomy in hereditary diffuse gastric cancer? Ann Surg Oncol 16:2678–2681

    Article  PubMed  Google Scholar 

  7. Ziogas D, Baltogiannis G, Fatouros M, Roukos DH (2008) Identifying and preventing high-risk gastric cancer individuals with CDH1 mutations. Ann Surg 247:714–715

    Article  PubMed  Google Scholar 

  8. Roukos DH (2010) Novel clinico-genome network modeling for revolutionizing genotype-phenotype-based personalized cancer care. Expert Rev Mol Diagn 10:33–48

    Article  PubMed  CAS  Google Scholar 

  9. Roukos DH (2009) Isolated tumor cells in breast cancer. N Engl J Med 361:1994–1995

    Article  PubMed  CAS  Google Scholar 

  10. Roukos DH, Tzakos A, Zografos G (2009) Current concerns and challenges towards tailored anti-angiogenic therapy in cancer. Expert Rev Anticancer Ther 9:1413–1416

    Article  PubMed  Google Scholar 

  11. Roukos DH (2009) Genome-wide association studies: how predictable is a person’s cancer risk? Expert Rev Anticancer Ther 9:389–392

    Article  PubMed  Google Scholar 

  12. Roukos DH, Ziogas D (2009) Human genetic and structural genomic variation: would genome-wide association studies be the solution for cancer complexity like Alexander the Great for the “Gordian Knot”? Ann Surg Oncol 16:774–775

    Article  PubMed  Google Scholar 

  13. Roukos DH (2010) Systems medicine: a real approach for future personalized oncology? Pharmacogenomics 11(3):283–287

    Article  PubMed  Google Scholar 

  14. Roukos DH (2010) Bionetworks-based personalized medicine versus comparative-effectiveness research or harmonization of both in cancer management? Expert Rev Mol Diagn 10(3):247–250

    Article  PubMed  Google Scholar 

  15. Roukos DH, Katsios C, Liakakos T (2010) Genotype-phenotype map and molecular networks: a promising solution in overcoming colorectal cancer resistance to targeted treatment. Expert Rev Mol Diagn 10(5):541–545

    Article  PubMed  CAS  Google Scholar 

  16. Ziogas D, Roukos DH (2009) Genetics and personal genomics for personalized breast cancer surgery: progress and challenges in research and clinical practice. Ann Surg Oncol 16(7):1771–1782

    Google Scholar 

  17. Roukos DH (2009) Breast cancer outcomes: the crucial role of the breast surgeon in the era of personal genetics and systems biology. Ann Surg 249(6):1067–1068

    Article  PubMed  Google Scholar 

  18. Roukos DH, Ziogas D (2010) From tumor size and HER2 status to systems oncology for very early breast cancer treatment. Expert Rev Anticancer Ther 10(2):123–128

    Article  PubMed  CAS  Google Scholar 

  19. Roukos DH (2010) Beyond HER2 and trastuzumab: heterogeneity, systems biology, and cancer origin research may guide the future for personalized treatment of very early but aggressive breast cancer. J Clin Oncol 28(17):e279–e280; author reply e282–3

    Article  PubMed  Google Scholar 

  20. Katsios C, Roukos DH (2010) Individual genomes and personalized medicine: life diversity and complexity. Per Med 7(4):347–350

    Article  CAS  Google Scholar 

Download references

Acknowledgements

There is no research support for this article.

Disclosures

Charalambos Batsis and Ioannis Makris have no conflicts of interest or financial ties to disclose.

Author information

Authors and Affiliations

  1. Department of Surgery, School of Medicine, University of Ioannina, 451 10, Ioannina, TK, Greece

    Charalambos Batsis

  2. Second Surgical Department, “G, Gennimatas” General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece

    Ioannis Makris

Authors
  1. Charalambos Batsis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ioannis Makris
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Charalambos Batsis.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Batsis, C., Makris, I. Optimizing locoregional staging in the preoperative setting of resectable esophageal cancer. Surg Endosc 25, 1344–1345 (2011). https://doi.org/10.1007/s00464-010-1283-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00464-010-1283-8

Keywords

Search

Navigation